We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Molecular Assay Compared to Blood Smear for Babesiosis Diagnosis

By LabMedica International staff writers
Posted on 10 Jun 2015
Print article
Image: Photomicrograph of a thin blood smear showing different stages of Babesia microti in erythrocytes (Photo courtesy of the University of Utah).
Image: Photomicrograph of a thin blood smear showing different stages of Babesia microti in erythrocytes (Photo courtesy of the University of Utah).
A real-time quantitative polymerase chain reaction (qPCR) has been used to determine the number of DNA copies/mL of blood of a Babesia microti gene in infected patients.

Although microscopic examination of a peripheral blood smear is the most commonly used diagnostic method to diagnose active Babesia infection in symptomatic patients, polymerase chain reaction (PCR) assays are also being increasingly employed as well.

Scientists at New York Medical College (Valhalla, NY, USA) obtained blood samples from 36 patients whose median age was 62.5 years and 75.0% were male with at least one qPCR-positive blood sample were included in this analysis, including 16 with serial blood samples. Blood samples were evaluated by Wright or Giemsa-stained thick and thin blood smears with at least 300 oil immersion fields were examined on a thin blood smear before reporting a negative test result.

Extracted DNA was eluted from the blood samples using a commercial DNA extraction kit, the QIAamp DNA Blood Mini (Qiagen; Valencia, CA, USA) and qPCR was performed on the 7500 Fast Dx Real-Time PCR instrument (Applied Biosystems; Foster City, CA, USA). Of the 36 patients, 32 had one or more positive blood smears for ring forms consistent with B. microti, though not all of the blood samples with positive smears were simultaneously tested by qPCR.

Based on testing of serial blood samples, it was demonstrated that the smear became negative while the qPCR remained positive. A moderate to strong correlation was found between the DNA copy number and the number of infected erythrocytes per milliliter of blood. Based on limited data, the DNA copy number fell by a mean of 4.1% to 12.9% per day on active treatment and by 3.5% to 7.1% per day off therapy.

The authors concluded that the qPCR method is more sensitive than microscopic examination of the blood smear for detection of B. microti infection. This assay should enable an assessment of the rate of parasite clearance over time even in patients who have become smear negative. Quantitative test results for parasite clearance may be useful in evaluating the relative efficacy of various antiparasitic drug regimens and other therapeutic modalities. The study was published in the June 2015 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

New York Medical College
Qiagen 
Applied Biosystems 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.